ZIMMER BIOMET HOLDINGS, INC. (ZBH) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $3.20M; Additional Paid in Capital, Common StockUSD $10.22B; Treasury Stock, ValueUSD $9.39B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-163.90M.
- 2026-03-31: Common Stock, Value, IssuedUSD $3.20M; Additional Paid in Capital, Common StockUSD $10.20B; Treasury Stock, ValueUSD $9.14B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-190.40M.
- 2025-12-31: Common Stock, Value, IssuedUSD $3.20M; Additional Paid in Capital, Common StockUSD $10.18B; Treasury Stock, ValueUSD $8.89B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-205.70M.
- 2025-09-30: Common Stock, Value, IssuedUSD $3.20M; Additional Paid in Capital, Common StockUSD $10.16B; Treasury Stock, ValueUSD $8.64B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-283.80M.
ZIMMER BIOMET HOLDINGS, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Treasury Stock, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Treasury Stock, Common, Shares shares | Treasury Stock, Value, Acquired, Cost Method USD | Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD | Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD | AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax USD | Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax USD | Treasury Stock, Shares, Acquired shares | Noncontrolling Interest, Increase from Sale of Parent Equity Interest USD | Noncontrolling Interest, Increase from Business Combination USD | Treasury Stock Acquired, Average Cost Per Share USD/shares | Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax USD | Treasury Stock, Shares shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.20M | $10.22B | $9.39B | $-163.90M | $11.96B | $12.62B | $12.63B | 128.80M | 3 month · $252.40M 6 month · $504.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $3.20M | $10.20B | $9.14B | $-190.40M | $11.80B | $12.67B | $12.68B | 125.90M | 3 month · $252.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $3.20M | $10.18B | $8.89B | $-205.70M | $11.61B | $12.70B | $12.71B | 123.20M | 12 month · $484.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $3.20M | $10.16B | $8.64B | $-283.80M | $11.52B | $12.76B | $12.77B | 120.50M | 9 month · $231.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $3.20M | $10.11B | $8.64B | $-284.50M | $11.34B | $12.53B | $12.53B | 120.50M | 6 month · $231.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $3.20M | $10.09B | $8.64B | $-287.30M | $11.23B | $12.40B | $12.40B | 120.50M | 3 month · $231.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $3.20M | $10.04B | $8.41B | $-262.80M | $11.10B | $12.47B | $12.48B | 118.40M | 12 month · $844.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $3.20M | $10.02B | $8.35B | $-202.20M | $10.90B | $12.37B | $12.38B | 117.80M | 3 month · $603.30M 9 month · $786.70M | 9 month · $55.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $3.20M | $9.97B | $7.74B | $-195.20M | $10.70B | $12.74B | $12.75B | 112.30M | 3 month · $95.40M 6 month · $183.40M | 6 month · $37.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $3.20M | $9.95B | $7.65B | $-211.20M | $10.51B | $12.60B | $12.61B | 111.50M | 3 month · $88.00M | 3 month · $19.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $3.20M | $9.85B | $7.56B | $-191.00M | $10.38B | $12.48B | $12.49B | 110.60M | 12 month · $698.40M | 12 month · $83.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $3.20M | $9.80B | $7.12B | $-186.50M | $10.01B | $12.51B | $12.52B | 107.00M | 9 month · $258.30M | 9 month · $60.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $3.20M | $9.77B | $7.12B | $-177.80M | $9.90B | $12.37B | $12.38B | 107.00M | 3 month · $14.30M 6 month · $258.30M | 6 month · $40.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $3.20M | $9.69B | $7.11B | $-178.00M | $9.74B | $12.15B | $12.16B | (m) | 3 month · $244.00M | 3 month · $-19.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 106.90M |
| 2022-12-31 | $3.10M | $9.50B | $6.87B | $-179.30M | $9.56B | $12.02B | $12.03B | 104.80M | 12 month · $150.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 104.80M |
| 2022-09-30 | $3.10M | $9.46B | $6.72B | $-244.90M | $9.74B | $12.24B | $12.25B | (m) | (m) | 9 month · $-21.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 103.80M |
| 2022-06-30 | $3.10M | $9.42B | $6.72B | $-192.50M | $9.61B | $12.12B | $12.12B | (m) | (m) | 6 month · $-10.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 103.80M |
| 2022-03-31 | $3.10M | $9.39B | $6.72B | $-158.90M | $9.50B | $12.02B | $12.02B | (m) | (m) | 3 month · $-3.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 103.80M |
| 2021-12-31 | $3.10M | $9.31B | $6.72B | $-231.60M | $10.29B | $12.66B | $12.67B | (m) | (m) | 12 month · $-6.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 103.80M |
| 2021-09-30 | $3.10M | $9.30B | $6.72B | $-298.10M | $10.43B | $12.71B | $12.71B | (m) | (m) | 9 month · $8.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 103.80M |
| 2021-06-30 | $3.10M | $9.25B | $6.72B | $-287.00M | $10.33B | $12.58B | $12.58B | (m) | (m) | 6 month · $1.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 103.80M |
| 2021-03-31 | $3.10M | $9.20B | $6.72B | $-276.70M | $10.24B | $12.45B | $12.45B | (m) | (m) | 3 month · $300.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 103.80M |
| 2020-12-31 | $3.10M | $9.12B | $6.72B | $-297.80M | $10.09B | $12.19B | $12.20B | (m) | (m) | 12 month · $-35.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 103.80M |
| 2020-09-30 | $3.10M | $9.07B | $6.72B | $-287.00M | $9.80B | $11.87B | $11.88B | (m) | (m) | 9 month · $-31.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 103.80M |
| 2020-06-30 | $3.10M | $9.01B | $6.72B | $-265.80M | $9.61B | $11.64B | $11.64B | (m) | (m) | 6 month · $-24.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 103.80M |
| 2020-03-31 | $3.10M | $8.98B | $6.72B | $-255.10M | $9.87B | $11.88B | $11.88B | (m) | (m) | 3 month · $-13.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 103.80M |
| 2019-12-31 | $3.10M | $8.92B | $6.72B | $-241.90M | $10.43B | $12.39B | $12.39B | (m) | (m) | 12 month · $-30.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 103.90M |
| 2019-09-30 | $3.10M | $8.87B | $6.72B | $-223.20M | $10.16B | $12.08B | $12.09B | (m) | (m) | 9 month · $-16.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 103.90M |
| 2019-06-30 | $3.10M | $8.78B | $6.72B | $-171.80M | $9.77B | $11.66B | $11.66B | (m) | (m) | 6 month · $-10.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 103.90M |
| 2019-03-31 | $3.10M | $8.75B | $6.72B | $-183.50M | $9.69B | $11.53B | $11.54B | (m) | (m) | 3 month · $-6.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 103.90M |
| 2018-12-31 | $3.10M | $8.69B | $6.72B | $-187.40M | $9.49B | $11.27B | $11.28B | (m) | (m) | 12 month · $35.60M | (m) | (m) | (m) | (m) | 12 month · $5.20M | (m) | (m) | (m) | 103.90M |
| 2018-09-30 | $3.10M | $8.66B | $6.72B | $-168.10M | $10.44B | $12.22B | $12.22B | (m) | (m) | 9 month · $32.10M | (m) | (m) | (m) | (m) | 3 month · $5.20M 9 month · $5.20M | (m) | (m) | (m) | 103.80M |
| 2018-06-30 | $3.10M | $8.60B | $6.72B | $-163.00M | $10.33B | $12.04B | $12.04B | (m) | (m) | 6 month · $24.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 103.80M |
| 2018-03-31 | $3.10M | $8.58B | $6.72B | $-51.30M | $10.19B | $12.00B | $12.00B | (m) | (m) | 3 month · $12.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 103.80M |
| 2017-12-31 | $3.10M | $8.51B | $6.72B | $-83.20M | $10.02B | $11.74B | $11.74B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 103.90M |
| 2017-09-30 | $3.00M | $8.49B | $6.72B | $-159.90M | $8.84B | $10.45B | $10.45B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 103.90M |
| 2017-06-30 | $3.00M | $8.48B | $6.73B | $-264.40M | $8.79B | $10.28B | $10.28B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 104.00M |
| 2017-03-31 | $3.10M | $8.44B | $6.73B | $-423.80M | $8.65B | $9.93B | $9.93B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 104.00M |
| 2016-12-31 | $3.10M | $8.37B | $6.74B | $-434.00M | $8.47B | $9.67B | $9.67B | (m) | 12 month · $415.50M | (m) | (m) | (m) | (m) | 12 month · 4.20M | (m) | (m) | 12 month · 98.50 | (m) | 104.10M |
| 2016-12-13 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 104.10M |
| 2016-09-30 | $3.00M | $8.34B | $6.74B | $-303.40M | $8.44B | $9.75B | $9.75B | (m) | 9 month · $415.50M | (m) | (m) | (m) | (m) | 3 month · 0.00 9 month · 4.20M | (m) | (m) | 9 month · 98.50 | (m) | 104.20M |
| 2016-06-30 | $3.00M | $8.29B | $6.74B | $-339.30M | $8.33B | $9.55B | $9.55B | (m) | 6 month · $415.50M | (m) | (m) | (m) | (m) | 3 month · 0.00 6 month · 4.20M | (m) | (m) | 6 month · 98.50 | (m) | 104.20M |
| 2016-03-31 | $3.00M | $8.23B | $6.74B | $-242.90M | $8.41B | $9.66B | $9.66B | (m) | 3 month · $415.50M | (m) | (m) | (m) | (m) | 3 month · 4.20M | (m) | (m) | 3 month · 98.50 | (m) | 104.20M |
| 2015-12-31 | $3.00M | $8.20B | $6.33B | $-329.00M | $8.35B | $9.89B | $9.89B | (m) | 12 month · $150.00M | (m) | (m) | (m) | (m) | 12 month · 1.40M | (m) | (m) | 12 month · 106.01 | (m) | 100.00M |
| 2015-09-30 | $3.00M | $8.16B | $6.18B | $-253.10M | $8.26B | $9.99B | $9.99B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 98.60M |
| 2015-06-30 | $3.00M | $8.11B | $6.18B | $-103.00M | $8.29B | $10.12B | $10.12B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 98.60M |
| 2015-03-31 | $2.70M | $4.36B | $6.18B | $-76.50M | $8.50B | $6.61B | $6.61B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 98.60M |
| 2014-12-31 | $2.70M | $4.33B | $6.18B | $38.10M | $8.36B | $6.55B | $6.55B | (m) | 12 month · $400.50M | (m) | (m) | (m) | (m) | 12 month · 4.20M | (m) | (m) | 12 month · 94.57 | (m) | 98.70M |
| 2014-09-30 | $2.70M | $4.29B | $6.18B | $268.50M | $8.17B | $6.54B | $6.54B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 98.70M |
| 2014-06-30 | $2.70M | $4.24B | $6.19B | $356.10M | $8.04B | $6.45B | $6.45B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 98.70M |
| 2014-03-31 | $2.60M | $4.15B | $6.19B | $375.70M | $7.90B | $6.24B | $6.24B | (m) | 3 month · $400.50M | (m) | (m) | (m) | (m) | 3 month · 4.20M | (m) | (m) | 3 month · 94.57 | (m) | 98.70M |
| 2013-12-31 | $2.60M | $4.00B | $5.79B | $367.10M | $7.71B | $6.30B | $6.31B | (m) | 12 month · $719.00M | (m) | (m) | (m) | (m) | 12 month · 9.10M | (m) | (m) | 12 month · 78.88 | (m) | 94.50M |
| 2013-09-30 | $2.60M | $3.84B | $5.55B | $324.80M | $7.51B | $6.14B | $6.14B | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · 200.00K 9 month · 6.40M | (m) | (m) | 3 month · 83.92 9 month · 74.20 | (m) | 91.80M |
| 2013-06-30 | $2.60M | $3.73B | $5.53B | $296.90M | $7.39B | $5.89B | $5.89B | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · 900.00K 6 month · 6.20M | (m) | (m) | 3 month · 78.16 6 month · 73.88 | (m) | 91.70M |
| 2013-03-31 | $2.60M | $3.58B | $5.46B | $316.10M | $7.27B | $5.71B | $5.71B | (m) | 3 month · $392.00M | (m) | (m) | (m) | (m) | 3 month · 5.40M | (m) | (m) | 3 month · 73.18 | (m) | 90.80M |
| 2012-12-31 | $2.60M | $3.50B | $5.07B | $343.90M | $7.09B | $5.86B | $5.85B | (m) | 12 month · $485.60M | (m) | $445.50M | $400.00K | $106.10M | 12 month · 7.70M | (m) | (m) | 12 month · 63.39 | $4.10M | 85.50M |
| 2012-09-30 | $2.60M | $3.48B | $4.94B | $311.20M | $6.97B | $5.83B | $5.83B | (m) | 3 month · $97.60M 9 month · $345.70M | (m) | (m) | (m) | (m) | 3 month · 1.50M 9 month · 5.50M | (m) | (m) | 3 month · 62.61 9 month · 62.29 | $-19.60M | 83.40M |
| 2012-06-30 | $2.60M | $3.45B | $4.84B | $275.50M | $6.82B | $5.71B | $5.71B | (m) | 3 month · $106.50M 6 month · $248.10M | (m) | (m) | (m) | (m) | 3 month · 1.70M 6 month · 4.00M | (m) | (m) | 3 month · 63.75 6 month · 62.17 | $16.20M | 81.90M |
| 2012-03-31 | $2.60M | $3.42B | $4.73B | $327.60M | $6.64B | $5.65B | $5.66B | (m) | 3 month · $141.60M | (m) | (m) | (m) | (m) | 3 month · 2.30M | (m) | (m) | 3 month · 61.03 | $-5.20M | 80.20M |
| 2011-12-31 | $2.50M | $3.40B | $4.59B | $271.40M | $6.43B | $5.51B | $5.51B | (m) | 12 month · $1.05B | (m) | $399.40M | $0.00 | $117.90M | 12 month · 18.90M | (m) | 12 month · $8.50M | 12 month · 55.54 | $-10.10M | 77.90M |
| 2011-09-30 | $2.50M | $3.38B | $4.45B | $370.10M | $6.30B | $5.60B | $5.61B | (m) | 3 month · $549.30M 9 month · $906.50M | (m) | (m) | (m) | (m) | 3 month · 10.10M 9 month · 16.20M | (m) | (m) | 3 month · 54.30 9 month · 56.05 | $-19.00M | 75.20M |
| 2011-06-30 | $2.50M | $3.36B | $3.90B | $447.50M | $6.11B | (m) | $6.02B | (m) | 3 month · $121.10M 6 month · $357.20M | (m) | (m) | (m) | (m) | 3 month · 1.80M 6 month · 6.10M | (m) | (m) | 3 month · 66.21 6 month · 58.97 | $-45.00M | 65.10M |
| 2011-03-31 | $2.50M | $3.33B | $3.78B | $409.70M | $5.91B | (m) | $5.86B | (m) | 3 month · $236.10M | (m) | (m) | (m) | (m) | 3 month · 4.20M | (m) | (m) | 3 month · 55.83 | $-47.00M | 63.20M |
| 2010-12-31 | $2.50M | $3.29B | $3.55B | $321.00M | $5.70B | $5.77B | $5.77B | (m) | 12 month · $505.60M | (m) | $394.80M | $-200.00K | $69.60M | 12 month · 9.10M | (m) | (m) | 12 month · 55.26 | $-4.00M | 59.00M |
| 2010-09-30 | $2.50M | $3.27B | $3.44B | $325.30M | $5.66B | $5.82B | (m) | (m) | 3 month · $225.70M 9 month · $404.60M | (m) | (m) | (m) | (m) | 3 month · 4.20M 9 month · 7.10M | (m) | (m) | 3 month · 53.58 9 month · 56.61 | $-12.50M | 57.00M |
| 2010-06-30 | $2.50M | $3.25B | $3.22B | $224.10M | $5.47B | $5.73B | (m) | (m) | 3 month · $85.40M 6 month · $178.90M | (m) | (m) | (m) | (m) | 3 month · 1.40M 6 month · 2.90M | (m) | (m) | 3 month · 61.32 6 month · 60.95 | $29.80M | 52.80M |
| 2010-03-31 | $2.50M | $3.23B | $3.13B | $304.90M | $5.31B | $5.71B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 51.40M |
| 2009-12-31 | $2.50M | $3.21B | $3.04B | $358.60M | $5.10B | $5.64B | $5.64B | (m) | 12 month · $923.70M | (m) | $433.40M | $-1.60M | $-59.20M | (m) | (m) | (m) | (m) | $-14.00M | 49.90M |
| 2009-09-30 | $2.50M | $3.20B | $2.52B | $351.20M | $4.95B | $5.98B | $5.98B | (m) | 9 month · $-404.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 40.90M |
| 2009-06-30 | $2.50M | $3.18B | $2.45B | $282.40M | $4.80B | $5.81B | $5.81B | (m) | 6 month · $-337.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 39.50M |
| 2008-12-31 | $2.50M | $3.14B | $2.12B | $240.00M | $4.39B | $5.65B | $5.65B | (m) | 12 month · $-737.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 30.10M |
| 2007-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $5.45B | (m) | 12 month · $-576.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2006-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $4.92B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |